|
| |
| | | 00599 | | 30.09.1996 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Havrix 720 | Injektionssuspension | Injection suspension (Hepatitis-A-Virus Inactivatus (Hm175) 720U. / 0.5ml) | J07BC02 | | | 02 | Havrix 720 | | (Vaccinum Hepatitidis a Inactivatum Adsorbatum 720 U) | | |
|
|
|
